It confirmed the accuracy of the EPI test for discriminating high grade prostate cancer of ≥GG2 from benign and GG1 biopsies in men aged ≥50 years with a PSA of 2 to 10 ng/mL [91]. This evidence concerns the gene KLK3 and prostate carcinoma.